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Introduction
There were 54 patients with the juvenile onset of
systemic lupus erythematosus included in the retrospective
analysis, who were treated in the Institute of Rheumatol-
ogy in Warsaw in the years 2002-2012. The average age of
the onset of the illness in this group of patients was 12
years, the average time of observation was 3 years and 7
months.
Objectives
In 20 patients (37%) high level of IgG anticardiolipin
antibodies was discovered. High level of anticardiolipin
antybodies IgM was discovered in 6 patients (11.1%).
Lupus anticoagulant was determinated in 51 cases, in 17
was positive (31%). 8 patients had the tests for anti
beta2GPI carried out and in 4 cases it was positive. In
the group of 54 patients 22 (41%) presented prolonged
activated partial thromboplastin time (aPTT). Thrombo-
sis and thus antiphospholipid syndrome was confirmed
only in 1 case, it was thrombosis of popliteal vein.
In 8 children the presence of two different antipho-
spholipid antibodies and prolonged aPTT were found
with at least two hospitalizations. These children didn’t
have the symptoms of thrombosis during the time of
observation (average 3.5 years) - Immunological APS.
In the last 10 years in our department were hospita-
lized also 2 children with antiphospholipid syndrome,
they were diagnosed with Lupus-like disease. In the first
case there was thrombosis of common femoral vein and
deep femoral vein, the additional risk factor could be
Legionella pneumophila pneumonia. The other child
developed thrombosis of common iliac and external iliac
vein, additionaly deficiency of XII factor was discovered.
Among our Immunological APS patients there is also
the girl with Libmann-Sachs endocarditis in the course
of SLE, with aPTT, presence of lupus anticoagulant and
anticardiolipin antibodies.
Methods
Anticardiolipin antibodies were determinated by ELISA
method, for isotype IgG positive was more then 4 SD
(value 0.109), for isotype IgM more then 4 SD was
0.156. Lupus anticoagulant was determined due to
recommendation of International Society of Thrombosis
and Haemostasis. Anti beta 2 GPI antibodies were
determined by standardised ELISA method.
Results
There were two groups in which the clinical symptoms
and laboratory investigations were compared: the first
group consisted of the patients (24 people) who never
had antiphospholipid antybodies (aPL ab), in the second
group there were 20 patients who presented presence of
aPL ab, some of them had also prolonged aPTT. The
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incidence of laboratory markers of antiphospholipid
syndrome correlated with significantly higher ESR (33
versus 19), higher level of antinuclear antibodies (1769
versus 550), but the average values SLEDAI index were
comparable (10.4 versus 9.24). Among other symptoms,
the thrombocytopenia, proteinuria and vasculitis were
significantly more often in the group with laboratory
markers of antiphosphoslipid syndrome.
Conclusion
In spite of the high incidence of immunological mar-
kers of antiphosphoslipid syndrome thrombosis and
thus antiphospholipid syndrome is rare. The pathoge-
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